Acute ischemic myelopathy treated with intravenous thrombolysis: Four new cases and literature review.
Jeremy JankovicVincianne Rey BataillardNoëlle MercierChristophe BonvinPatrik MichelPublished in: International journal of stroke : official journal of the International Stroke Society (2019)
With appropriate acute imaging, intravenous thrombolysis after acute ischemic myelopathy is feasible and potentially safe within 4.5 h. Given the potential of benefit of thrombolysis in acute ischemic myelopathy, this treatment warrants further efficacy and safety studies.
Keyphrases
- liver failure
- pulmonary embolism
- spinal cord
- respiratory failure
- acute ischemic stroke
- drug induced
- aortic dissection
- high dose
- ischemia reperfusion injury
- high resolution
- hepatitis b virus
- cerebral ischemia
- case report
- spinal cord injury
- low dose
- oxidative stress
- mass spectrometry
- extracorporeal membrane oxygenation
- brain injury
- case control
- newly diagnosed